Literature DB >> 21996137

The 48-hour tetrahydrobiopterin loading test in patients with phenylketonuria: evaluation of protocol and influence of baseline phenylalanine concentration.

K Anjema1, G Venema, F C Hofstede, E C Carbasius Weber, A M Bosch, N M Ter Horst, C E M Hollak, C F Jonkers, M E Rubio-Gozalbo, E M C van der Ploeg, M C de Vries, R G Janssen-Regelink, M C H Janssen, H Zweers-van Essen, C C A Boelen, N A P van der Herberg-van de Wetering, M R Heiner-Fokkema, M van Rijn, F J van Spronsen.   

Abstract

BACKGROUND: The 24- and 48-hour tetrahydrobiopterin (BH4) loading test (BLT) performed at a minimum baseline phenylalanine concentration of 400 μmol/l is commonly used to test phenylketonuria patients for BH4 responsiveness. This study aimed to analyze differences between the 24- and 48-hour BLT and the necessity of the 400 μmol/l minimum baseline phenylalanine concentration.
METHODS: Data on 186 phenylketonuria patients were collected. Patients were supplemented with phenylalanine if phenylalanine was <400 μmol/l. BH4 20mg/kg was administered at T = 0 and T = 24. Blood samples were taken at T=0, 8, 16, 24 and 48 h. Responsiveness was defined as ≥ 30% reduction in phenylalanine concentration at ≥ 1 time point.
RESULTS: Eighty-six (46.2%) patients were responsive. Among responders 84% showed a ≥ 30% response at T = 48. Fifty-three percent had their maximal decrease at T = 48. Fourteen patients had ≥ 30% phenylalanine decrease not before T = 48. A ≥ 30% decrease was also seen in patients with phenylalanine concentrations <400 μmol/l.
CONCLUSION: In the 48-hour BLT, T = 48 seems more informative than T = 24. Sampling at T = 32, and T = 40 may have additional value. BH4 responsiveness can also be predicted with baseline blood phenylalanine <400 μmol/l, when the BLT is positive. Therefore, if these results are confirmed by data on long-term BH4 responsiveness, we advise to first perform a BLT without phenylalanine loading and re-test at higher phenylalanine concentrations when no response is seen. Most likely, the 48-hour BLT is a good indicator for BH4 responsiveness, but comparison with long term responsiveness is necessary.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21996137     DOI: 10.1016/j.ymgme.2011.09.024

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  5 in total

1.  Prevalence of tetrahydrobiopterine (BH4)-responsive alleles among Austrian patients with PAH deficiency: comprehensive results from molecular analysis in 147 patients.

Authors:  Elisabeth Sterl; Karl Paul; Eduard Paschke; Johannes Zschocke; Michaela Brunner-Krainz; Eva Windisch; Vassiliki Konstantopoulou; Dorothea Möslinger; Daniela Karall; Sabine Scholl-Bürgi; Wolfgang Sperl; Florian Lagler; Barbara Plecko
Journal:  J Inherit Metab Dis       Date:  2012-04-25       Impact factor: 4.982

2.  The Molecular Bases of Phenylketonuria (PKU) in New South Wales, Australia: Mutation Profile and Correlation with Tetrahydrobiopterin (BH4) Responsiveness.

Authors:  Gladys Ho; Ian Alexander; Kaustuv Bhattacharya; Barbara Dennison; Carolyn Ellaway; Sue Thompson; Bridget Wilcken; John Christodoulou
Journal:  JIMD Rep       Date:  2013-12-25

Review 3.  Phenylketonuria: translating research into novel therapies.

Authors:  Gladys Ho; John Christodoulou
Journal:  Transl Pediatr       Date:  2014-04

4.  Tetrahydrobiopterin responsiveness in phenylketonuria: prediction with the 48-hour loading test and genotype.

Authors:  Karen Anjema; Margreet van Rijn; Floris C Hofstede; Annet M Bosch; Carla E M Hollak; Estela Rubio-Gozalbo; Maaike C de Vries; Mirian C H Janssen; Carolien C A Boelen; Johannes G M Burgerhof; Nenad Blau; M Rebecca Heiner-Fokkema; Francjan J van Spronsen
Journal:  Orphanet J Rare Dis       Date:  2013-07-10       Impact factor: 4.123

5.  The neonatal tetrahydrobiopterin loading test in phenylketonuria: what is the predictive value?

Authors:  Karen Anjema; Floris C Hofstede; Annet M Bosch; M Estela Rubio-Gozalbo; Maaike C de Vries; Carolien C A Boelen; Margreet van Rijn; Francjan J van Spronsen
Journal:  Orphanet J Rare Dis       Date:  2016-01-29       Impact factor: 4.123

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.